Seeing Is Believing
Currently out of the existing stock ratings of Jason Cassorla, 47 are a BUY (78.33%), 13 are a HOLD (21.67%).
Analyst Jason Cassorla, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 47.92% that have a potential upside of 26.94% achieved within 202 days. Previously, Jason Cassorla worked at CITI.
Jason Cassorla’s has documented 114 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCA, HCA Holdings at 09-Apr-2025.
Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for CANO (CANO HEALTH) at 8/10/2022. The price target of $7 was fulfilled within 14 days with a profit of $2.26 (47.68%) receiving and performance score of 34.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 2 months 29 days ago
(26-Mar-2024)
1/5 (20%)
$4.31 (27.47%)
48
Hold
$10
$-0.05 (-0.50%)
$10
1 years 3 months 17 days ago
(07-Mar-2024)
3/3 (100%)
$0.1 (1.01%)
46
Sell
$11
$0.95 (9.45%)
$19
1 years 9 months 19 days ago
(05-Sep-2023)
1/2 (50%)
$2.29 (26.29%)
49
Hold
$13
$2.95 (29.35%)
$20
1 years 10 months 9 days ago
(15-Aug-2023)
0/5 (0%)
$1.86 (16.70%)
Buy
$13
$6.51 (100.31%)
$28
1 years 10 months 10 days ago
(15-Aug-2023)
1/3 (33.33%)
$4.47 (25.29%)
17
Which stock is Jason Cassorla is most bullish on?
Which stock is Jason Cassorla is most reserved on?
What Year was the first public recommendation made by Jason Cassorla?